Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion

Documenti analoghi

• Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
  di: Montalbán del Barrio, Itsaso, et al.
  Pubblicazione: (2016)
• Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells
  di: Diessner, Joachim, et al.
  Pubblicazione: (2013)
• The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
  di: Roberts, Veena, et al.
  Pubblicazione: (2014)
• Extracellular Generation of Adenosine by the Ectonucleotidases CD39 and CD73 Promotes Dermal Fibrosis
  di: Fernández, Patricia, et al.
  Pubblicazione: (2013)
• Human CD4(+)CD39(+) regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73(+) exosomes or CD73(+) cells
  di: Schuler, P J, et al.
  Pubblicazione: (2014)